Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.

Saved in:
Bibliographic Details
Title: Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.
Authors: Cao Y; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Li Q; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Guo W; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Xu M; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Fang K; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Wang F; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Zhang R; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Li L; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Wei J; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Liu Z; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Liang C; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Zhai W; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Ma Q; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Chen X; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Cao W; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Yang D; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., He Y; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Pang A; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Feng S; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Han M; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Sun J; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China., Jiang E; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.
Source: Frontiers in immunology [Front Immunol] 2025 Nov 28; Vol. 16, pp. 1626775. Date of Electronic Publication: 2025 Nov 28 (Print Publication: 2025).
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41394817
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cao+Y%22">Cao Y</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+Q%22">Li Q</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Guo+W%22">Guo W</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Xu+M%22">Xu M</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Fang+K%22">Fang K</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wang+F%22">Wang F</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhang+R%22">Zhang R</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Wei+J%22">Wei J</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Liang+C%22">Liang C</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Zhai+W%22">Zhai W</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Ma+Q%22">Ma Q</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Chen+X%22">Chen X</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Cao+W%22">Cao W</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Yang+D%22">Yang D</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22He+Y%22">He Y</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Pang+A%22">Pang A</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Feng+S%22">Feng S</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Han+M%22">Han M</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Sun+J%22">Sun J</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Jiang+E%22">Jiang E</searchLink>; Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Tianjin, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Nov 28; Vol. 16, pp. 1626775. <i>Date of Electronic Publication: </i>2025 Nov 28 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41394817
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1626775
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1626775
    Titles:
      – TitleFull: Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cao Y
      – PersonEntity:
          Name:
            NameFull: Li Q
      – PersonEntity:
          Name:
            NameFull: Guo W
      – PersonEntity:
          Name:
            NameFull: Xu M
      – PersonEntity:
          Name:
            NameFull: Fang K
      – PersonEntity:
          Name:
            NameFull: Wang F
      – PersonEntity:
          Name:
            NameFull: Zhang R
      – PersonEntity:
          Name:
            NameFull: Li L
      – PersonEntity:
          Name:
            NameFull: Wei J
      – PersonEntity:
          Name:
            NameFull: Liu Z
      – PersonEntity:
          Name:
            NameFull: Liang C
      – PersonEntity:
          Name:
            NameFull: Zhai W
      – PersonEntity:
          Name:
            NameFull: Ma Q
      – PersonEntity:
          Name:
            NameFull: Chen X
      – PersonEntity:
          Name:
            NameFull: Cao W
      – PersonEntity:
          Name:
            NameFull: Yang D
      – PersonEntity:
          Name:
            NameFull: He Y
      – PersonEntity:
          Name:
            NameFull: Pang A
      – PersonEntity:
          Name:
            NameFull: Feng S
      – PersonEntity:
          Name:
            NameFull: Han M
      – PersonEntity:
          Name:
            NameFull: Sun J
      – PersonEntity:
          Name:
            NameFull: Jiang E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 11
              Text: 2025 Nov 28
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1